Competition Agency began to study the
pharmaceutical market to reveal monopolists or cartels. Currently, the
information is being collected and processed.
is yet unknown when the first stage and the study are planned to be completed.
The monitoring will be conducted not in separate pharmacy chains, but in the entire industry
as a whole, and envisages legal and
monitoring group is studying the pharmaceutical market to reveal any violations of antitrust laws. The Agency
will study the cost of medicines
when imported, and at what price they
are sold by local companies. We should
find out whether there are monopolies or cartels on the market to hold unfair and high drug prices, ” the Agency
is supposed to study the prices of 12,000 most popular medicines on the market.
Head of the Competition Agency Nodar Khaduri said in 2019 that the
competition authorities would
begin to study the situation on the Georgian pharmaceutical market.
This is a long-term project that
will be implemented in two stages.
“We are holding preliminary
consultations with business community and non-governmental sector
on the drugs to be explored. Most likely, at the first stage, the
most popular and best-selling medicines will be studied, ” Nodar